Welcome to our dedicated page for Datametrex Ai Li news (Ticker: DTMXF), a resource for investors and traders seeking the latest updates and insights on Datametrex Ai Li stock.
The Datametrex AI Limited (DTMXF) news page on Stock Titan aggregates company announcements and updates related to its activities in Technology Solutions, Artificial Intelligence, fintech payments, and healthcare. Datametrex regularly issues news releases covering its subsidiaries, new contracts, acquisitions, and operational developments.
Investors and followers can review updates on Datametrex Korea, the company’s wholly owned subsidiary that secures IT infrastructure and technology solutions purchase orders from large global enterprises. These items often highlight new purchase orders, revenue expectations tied to those orders, and commentary on the company’s "land and expand" approach with global partners.
The news feed also features developments from Paymetrex Payment Solutions Inc., another wholly owned subsidiary focused on payment technologies. Recent releases describe a Technology Licensing Agreement with AnywhereCommerce Inc., plans to market payment solutions under the YuzuPay brand, and the acquisition of the Yuzu Payment Solution from Firstpayment Inc., including related patents and intellectual property.
Healthcare-related news appears through Imagine Health Medical Clinics Ltd., Datametrex’s wholly owned healthcare subsidiary. Announcements include clinic relocations in Calgary and Edmonton, the opening of new facilities, the launch of walk-in services for urgent, non-emergency care, and the addition of new physicians to expand capacity for family medicine and specialized medical services.
By following this page, readers can access a chronological record of Datametrex’s disclosed activities across technology, payments, and healthcare. The coverage includes corporate strategy updates, subsidiary milestones, and participation in capital markets events, helping users understand how the company presents its progress and business initiatives over time.
Datametrex AI (OTC:DTMXF) said its subsidiary Paymetrex and AnywhereCommerce entered a royalty-bearing license on March 17, 2026, covering portions of Paymetrex's U.S. and Canadian patents related to secure transaction processing and mobile acceptance architectures.
The release links the license to the rapidly expanding SoftPOS market, cites Juniper Research projecting SoftPOS transaction value of $540 billion by 2030 (from $22.9 billion in 2025), and notes AnywhereCommerce will deploy the licensed technology while Paymetrex will use AI analytics to prioritize licensing opportunities.
Datametrex (OTC:DTMXF) announced on March 10, 2026 the integration of AI capabilities into its EMR platform to assist physicians at the point of care. Key features include automated clinical documentation, intelligent document classification, real-time charting suggestions, and AI-generated post-visit care plans. The company emphasized clinician control over final clinical and prescribing decisions and compliance with patient-data regulations. Datametrex positions the upgrade as a workflow-efficiency measure to reduce administrative burden and support follow-up care and chronic condition management.
Datametrex (OTC:DTMXF) said its subsidiary Paymetrex engaged Pelent Patent Analytics effective February 13, 2026 to accelerate a patent licensing and monetization program.
Pelent's AI, trained on confidential licensing campaigns, will support target identification, prioritize enforcement/licensing, and provide Evidence of Use services under a four-month initial term.
Datametrex (OTC:DTMXF) received a Purchase Order of approximately $1,000,000 from a Fortune 500 conglomerate headquartered in South Korea on February 18, 2026. The order is for Nutanix-based hyperconverged infrastructure software licenses and carries an estimated profit margin of ~53%.
This P.O. validates Datametrex's data centre operations and supports its land-and-expand strategy, managed services platform, and efforts to build a predictable, recurring revenue base via Datametrex Korea.
Datametrex (OTC:DTMXF) received a $500,000 purchase order on February 6, 2026 from a Fortune 500 client in South Korea for data centre operations and infrastructure solutions. The order carries an estimated profit margin of ~20% and supports commercialization of the company's HCI-based private cloud and managed services platform.
The engagement highlights demand for AI-enabled infrastructure, GPU optimization, and scalable managed services while reinforcing Datametrex Korea's role in delivery and the company’s focus on recurring revenue growth through integrated infrastructure solutions.
Datametrex (OTC:DTMXF) announced Paymetrex launched a U.S. patent licensing program and signed a first non-exclusive license dated February 6, 2026.
Under the agreement Paymetrex will receive US$400,000 annually for the remaining life of the applicable patents. The portfolio lists nine U.S. and two Canadian patents and the company plans AI-driven licensing and portfolio expansion.
Datametrex (OTC:DTMXF) is expanding into modern data centre operations and infrastructure solutions, deploying Nutanix-based hyperconverged infrastructure (HCI) to unify servers, storage and networking.
The company reports successful deployments in South Korea, plans North American rollouts, and offers end-to-end services under an HCI SaaS model that aims to generate recurring revenue via long-term service and maintenance contracts. Datametrex also highlights AI-driven features such as load sharing and GPU optimization and is exploring data management with proprietary AI and third-party quantum servers.
Datametrex (OTC:DTMXF) subsidiary Paymetrex launched a patent licensing program to monetize its mobile payments IP portfolio, which includes nine issued U.S. and Canadian patents filed as early as 2011.
Paymetrex says portions of the portfolio are already licensed; the program targets payment processors, fintechs, merchants and infrastructure providers operating in large, fast-growing mobile wallet markets.
Datametrex AI (OTC:DTMXF) will participate in the AlphaNorth Capital Event hosted by CEM from January 16–18, 2026. The event schedules one-on-one meetings for growth-stage companies in Resource, Technology, Biotech, and Special Situations sectors to meet capital markets participants and professional investors. Datametrex said it will discuss its progress, strategy, and growth initiatives with existing and prospective investors. Event details are available on the conference website and participation runs across the full day of scheduled meetings.
Datametrex (OTC:DTMXF) announced that its Korea subsidiary secured new purchase orders with a combined value of approximately CAD $400,000 on January 8, 2026. The orders are expected to generate about CAD $400,000 in revenue with an estimated profit margin of 17.5%. The company said the contracts support its global growth strategy and "land and expand" approach, reinforcing Datametrex's role as a provider of IT infrastructure and technology solutions to large global enterprises.
Management highlighted continued demand from enterprise partners and noted the Korean subsidiary as a key contributor to revenue growth.